Please login to the form below

Not currently logged in
Email:
Password:

Atlas Genetics appoints Jeffery Luber as CEO

Former CEO Dr John Clarkson will move into an executive chairman position

Atlas Genetics has appointed its new chief executive officer in the form of Jeffrey Luber, as he succeeds Dr John Clarkson who transitions into executive chairman.

Luber also joins the company’s board following experience in the life sciences industry and holding multiple leadership roles including CEO of EXACT Sciences.

He said: “I am thrilled to join Atlas Genetics given the power of its platform, the strength of its board and leadership team, and its experience investor syndicate.

“As diagnostic testing increasingly becomes more decentralised, I look forward to working with the team to make Atlas the leading global player in POC testing.”

Prior to his new role at Atlas, Luber most recently led the return to growth and sale of Good Start Genetics to Invitae Corp, producing strategic partnerships with Roche Diagnostics and Amazon.

Dr John Clarkson, founding CEO, Atlas Genetics, said: “Jeff’s proven track record and extensive experience in the commercialisation of in vitro diagnostics will be invaluable as we enter the next, exciting phase of growth aimed at improving the diagnosis and treatment of conditions affecting women and families.”

11th October 2017

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics